Products
Latest News
FAQ
Log in
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
2
clinical trials
|
View Analysis
Sort by:
Newest First
Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA
Phase 2
Recruiting
Conditions
Warm Autoimmune Hemolytic Anemia
Interventions
Drug: Zanubrutinib
Subscribe
First Posted Date
2023-06-28
Last Posted Date
2024-04-26
Lead Sponsor
Chen Miao
Target Recruit Count
22
Registration Number
NCT05922839
Locations
🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Subscribe
The Effect of Eye Movement Desensitization and Reprocessing Intervention in Hypertension Patient.
Not Applicable
Completed
Conditions
Heart Rate Variability
Anxiety
Blood Pressure
Eye Movement Desensitization and Reprocessing Intervention
Interventions
Behavioral: Eye Movement Desensitization and Reprocessing
Subscribe
First Posted Date
2023-05-01
Last Posted Date
2023-05-01
Lead Sponsor
Miao-Yi Chen
Target Recruit Count
110
Registration Number
NCT05836181
Locations
🇨🇳
Chen, miao-yi, Taipei, Neihu, Taiwan
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy